NK cells: Elusive participants in transplantation immunity and tolerance

Current Opinion in Immunology

Volumn 22, Issue 5, 2010, Pages 649-654

  Gill, Ronald G ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; FC RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2 RECEPTOR ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; OX40 LIGAND; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN PRESENTING CELL; CARDIAC ALLOGRAFT VASCULOPATHY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INTERACTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPHENOTYPING; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TRANSPLANTATION;

ANIMALS; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 78049271323     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.09.005     Document Type: Review

References (46)

1. Lanier L.L. NK cell recognition. Annu Rev Immunol 2005, 23:225-274.
2. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat Immunol 2008, 9:503-510.
3. Lanier L.L. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008, 9:495-502.
4. Karre K., Ljunggren H.G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986, 319:675-678.
5. Kean L.S., Hamby K., Koehn B., Lee E., Coley S., Stempora L., Adams A.B., Heiss E., Pearson T.C., Larsen C.P. NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. Am J Transplant 2006, 6:292-304.
6. Hamby K., Trexler A., Pearson T.C., Larsen C.P., Rigby M.R., Kean L.S. NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent bu NKG2D-independent mechanism. Am J Transplant 2007, 7:1884-1896.
7. Maier S., Tertilt C., Chambron N., Gerauer K., Huser N., Heidecke C., Pfeffer K. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001, 7:557-562.
8. McNerney M.E., Lee K.-M., Zhou P., Molinero L., Mashayekhi M., Guzior D., Sattar H., Kuppireddi S., Wang C.-R., Kumar V., et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant 2006, 6:505-513.
9. Kroemer A., Xiao X., Degauque N., Edtinger K., Wei H., Demirci G., Li X.C. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008, 180:7818-7826.
10. Ito A., Shimura H., Nitahara A., Tomiyama K., Ito M., Kanekura T., Okumura K., Yagita H., Kawai K. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. Int Immunol 2008, 20:1343-1349.
11. Garrod K.R., Liu F.C., Forrest L.E., Parker I., Kang S.M., Cahalan M.D. NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity. J Immunol 2010, 184:2329-2336.
12. Yu G., Xu X., Vu M.D., Kilpatrick E.D., Li X.C. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006, 203:1851-1858.
13. Laffont S., Seillet C., Ortaldo J., Coudert J.D., Guery J.C. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor dedritic cells. Blood 2008, 112:661-671.
14. Uehara S., Chase C.M., Kitchens W.H., Rose H.S., Colvin R.B., Russell P.S., Madsen J.C. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005, 175:3424-3430.
15. Hidalgo L.G., Sis B., Sellares J., Campbell P.M., Mengel M., Einecke G., Chang J., Halloran P.F. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvment in antibody-mediated rejection. Am J Transplant 2010, 10:1812-1822.
16. Bonnema J.D., Karnitz L.M., Schoon R.A., Abraham R.T., Leibson P.J. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J Exp Med 1994, 180:1427-1435.
17. Degli-Esposti M.A., Smyth M.J. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005, 5:112-124.
18. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tisues. Nat Rev Immunol 2002, 2:264-957.
19. Piccioli D., Sbrana S., Melandri E., Valiante N.M. Contact-dependent stimulation and inibition of dendritic cells by natural killer cells. J Exp Med 2002, 195:335-341.
20. Fernandez N.C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., Perricaudet M., Tursz T., Maraskovsky E., Zitvogel L. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999, 5:405-411.
21. Lucas M., Schachterle W., Oberle K., Aichele P., Diefenback A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007, 26:503-517.
22. Mailliard R.B., Son Y.I., Redlinger R., Coates P.T., Giermasz A., Morel P.A., Storkus W.J., Kalinski P. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 2003, 171:2366-2373.
23. Coudert J.D., Coureau C., Guery J.C. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th Type 2 responses to transplantation antigens. J Immunol 2002, 169:2979-2987.
24. Semino C., Angelini G., Piggi A., Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell actvation and release of DC maturation factor HMGB1. Blood 2005, 106:609-616.
25. Ferlazzo G., Morandi B., D'Agostino A., Meazza R., Melioli G., Moretta A., Moretta L. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 2003, 33:306-313.
26. Beilke J.N., Kuhl N.R., Van Kaer L., Gill R.G. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005, 11:1059-1065.
27. Yamada A., Chandraker A., Laufer T.M., Gerth A.J., Sayegh M.H., Auchincloss H.J. Cutting edge: recipient MHC class II expression is required to acheive long-term survival of murine cardiac allografts after costimulatory blockade. J Immunol 2001, 167:5522-5526.
28. Luo X., Pothoven K.L., McCarthy D., DeGutes M., Martin A., Getts D.R., Xia G., He J., Zhang X., Kaufman D.B., et al. ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proc Natl Acad Sci (USA) 2008, 105:14527-14532.
29. Tsang J.Y., Tanriver Y., Jiang S., Xue S., Ratnasothy K., Chen D., Stauss H.J., Bucy R.P., Lombardi G., Lechler R. Conferring indirect allospecificity on CD4+ CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest 2008, 118:3619-3628.
30. Maroof A., Beattie L., Zubairi S., Svensson M., Stager S., Kaye P.M. Postranscriptional regulation of Il10 gene expression allows natural killer cells to express immunoregulatory function. Immunity 2008, 29:295-305.
31. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004, 5:1260-1265.
32. Laouar Y., Sutterwala F.S., Gorelik L., Flavell R.A. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol 2005, 6:600-607.
33. Zingoni A., Sornasse T., Cocks B.G., Tanaka Y., Santoni A., Lanier L.L. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol 2004, 173:3716-3724.
34. Rabinovich B.A., Shannon J., Su R.C., Miller R.G. Stress renders T cell blasts sensitive to killing by activated syngeneic NK cells. J Immunol 2000, 165:2390-2397.
35. Waggoner S.N., Taniguchi R.T., Mathew P.A., Kumer V., Welsh R.M. Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis. J Clin Invest 2010, 120:1925-1939.
36. Rivas M.N., Hazzan M., Weatherly K., Gaudray F., Salmon I., Braun M.Y. NK cell regulation of CD4 T cell-mediated graft-versus-host disease. J Immunol 2010, 184:6790-6798.
37. Olson J.A., Levenson-Gower D., Gill S., Baker J., Beilhack A., Negrin R.S. NK cells mediate reduction of GVHD by inhibitin activated, alloreactaive T cells while retaining GVL effects. Blood 2010, 115:4293-4301.
38. Zecher D., Li Q., Oberbarnscheidt M.H., Demetris A.J., Shlomchik W.D., Rothstein D.M., Lakkis F.G. NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8+ T cells. J Immunol 2010, 184:6649-6657.
39. Jinushi M., Takehara T., Tatsummi T., Yamaguchi S., Sakamori R., Hiramatsu N., Kanto T., Ohkawa K., Hayashi N. Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4+CD25+ T cells with PD-1-dependent regulatory activities. Immunology 2007, 120:73-82.
40. Vacca P., Cantoni C., Vitale M., Prato C., Canegallo F., Ragni N., Moretta L., Mingari M.C. Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosupppression. Proc Natl Acad Sci 2010, 107:11918-11923.
41. Ghiringhelli F., Menard C., Terme M., Flament C., Taieb J., Chaput N., Puig P.E., Novault S., Escudeir B., Vivier E., et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions ian a transforming growth factor-b-dependent manner. J Exp Med 2005, 202:1075-1085.
42. Terme M., Chaput N., Combadiere B., Ma A., Ohteki T., Zitvogel L. Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells. J Immunol 2008, 4679-4686.
43. Feuerer M., Shen Y., Littman D.R., Benoist C., Mathis D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 2009, 31:654-664.
44. Brillard E., Pallandre J., Chalmers D., Ryffel B., Radlovic A., Seilles E., Rohrlich P.S., Pivot X., Tiberghien P., Saas P., et al. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphoytes. Exp Hematol 2007.
45. Roy S., Barnes P.F., Garg A., Wu S., Cosman D., Vankayalapati R. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Immunol 2008, 180:1729-1736.
46. Sun J.C., Beilke J.N., Lanier L.L. Adaptive immune features of natural killer cells. Nature 2009, 457:557-561.